Is Glucagon Receptor Activation the Thermogenic Solution for Treating Obesity?
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Is Glucagon Receptor Activation the Thermogenic Solution for Treating Obesity?
Authors
Keywords
-
Journal
Frontiers in Endocrinology
Volume 13, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-04-25
DOI
10.3389/fendo.2022.868037
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Brown adipose tissue is associated with cardiometabolic health
- (2021) Tobias Becher et al. NATURE MEDICINE
- Glucagon-receptor signaling regulates weight loss via central KLB receptor complexes
- (2021) Shelly R. Nason et al. JCI Insight
- Therapeutic potential of mitochondrial uncouplers for the treatment of metabolic associated fatty liver disease and NASH
- (2021) Leigh Goedeke et al. Molecular Metabolism
- Physiology of Energy Expenditure in the Weight‐Reduced State
- (2021) Eric Ravussin et al. Obesity
- The genetics of obesity: from discovery to biology
- (2021) Ruth J. F. Loos et al. NATURE REVIEWS GENETICS
- Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes
- (2021) Juan P. Frías et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prolonged Glucagon Infusion Does Not Affect Energy Expenditure in Individuals with Overweight/Obesity: A Randomized Trial
- (2021) Katie L. Whytock et al. Obesity
- Challenges in tackling energy expenditure as obesity therapy: From preclinical models to clinical application
- (2021) Mona C. Löffler et al. Molecular Metabolism
- Effects on weight loss and glycemic control with SAR441255, a potent unimolecular peptide GLP-1/GIP/GCG receptor triagonist
- (2021) Martin Bossart et al. Cell Metabolism
- Anti-obesity drug discovery: advances and challenges
- (2021) Timo D. Müller et al. NATURE REVIEWS DRUG DISCOVERY
- Joint international consensus statement for ending stigma of obesity
- (2020) Francesco Rubino et al. NATURE MEDICINE
- Leveraging the Gut to Treat Metabolic Disease
- (2020) Ruth E. Gimeno et al. Cell Metabolism
- 8. Obesity Management for the Treatment of Type 2 Diabetes: Standards of Medical Care in Diabetes—2021
- (2020) DIABETES CARE
- Loss of glucagon signaling alters white adipose tissue browning
- (2019) Logan K. Townsend et al. FASEB JOURNAL
- Obesity: global epidemiology and pathogenesis
- (2019) Matthias Blüher Nature Reviews Endocrinology
- Intranasal glucagon acutely increases energy expenditure without inducing hyperglycaemia in overweight/obese adults
- (2019) Priska Stahel et al. DIABETES OBESITY & METABOLISM
- The liver as an endocrine organ - linking NAFLD and insulin resistance
- (2019) Matthew J Watt et al. ENDOCRINE REVIEWS
- Metabolic Determinants of Weight Gain in Humans
- (2019) Paolo Piaggi Obesity
- The brown adipose tissue glucagon receptor is functional but not essential for control of energy homeostasis in mice
- (2019) Jacqueline L. Beaudry et al. Molecular Metabolism
- BCAA catabolism in brown fat controls energy homeostasis through SLC25A44
- (2019) Takeshi Yoneshiro et al. NATURE
- Going Back to the Biology of FGF21: New Insights
- (2019) Jo E. Lewis et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Glucagon-like peptide 1 (GLP-1)
- (2019) T.D. Müller et al. Molecular Metabolism
- Glucagon-Receptor Signaling Reverses Hepatic Steatosis Independent of Leptin Receptor Expression
- (2019) Shelly R Nason et al. ENDOCRINOLOGY
- Glucagon Regulation of Energy Expenditure
- (2019) Maximilian Kleinert et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Opportunities and challenges in the therapeutic activation of human energy expenditure and thermogenesis to manage obesity
- (2019) Kong Y. Chen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Projected U.S. State-Level Prevalence of Adult Obesity and Severe Obesity
- (2019) Zachary J. Ward et al. NEW ENGLAND JOURNAL OF MEDICINE
- Liraglutide decreases energy expenditure and does not affect the fat fraction of supraclavicular brown adipose tissue in patients with type 2 diabetes
- (2019) Huub J. van Eyk et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- Glucagon-receptor Signaling Regulates Energy Metabolism Via Hepatic Farnesoid X Receptor and Fibroblast Growth Factor 21
- (2018) Teayoun Kim et al. DIABETES
- MEDI0382, a GLP-1 and glucagon receptor dual agonist, in obese or overweight patients with type 2 diabetes: a randomised, controlled, double-blind, ascending dose and phase 2a study
- (2018) Philip Ambery et al. LANCET
- The Common and Distinct Features of Brown and Beige Adipocytes
- (2018) Kenji Ikeda et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Anti-Obesity Therapy: from Rainbow Pills to Polyagonists
- (2018) T. D. Müller et al. PHARMACOLOGICAL REVIEWS
- New Advances in Adaptive Thermogenesis: UCP1 and Beyond
- (2018) Edward T. Chouchani et al. Cell Metabolism
- Investigational glucagon receptor antagonists in Phase I and II clinical trials for diabetes
- (2017) André J. Scheen et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Current pharmacotherapy for obesity
- (2017) Gitanjali Srivastava et al. Nature Reviews Endocrinology
- Economic Burden of Obesity: A Systematic Literature Review
- (2017) Maximilian Tremmel et al. International Journal of Environmental Research and Public Health
- Robust anti-obesity and metabolic effects of a dual GLP-1/glucagon receptor peptide agonist in rodents and non-human primates
- (2016) S. J. Henderson et al. DIABETES OBESITY & METABOLISM
- Targeting adipose tissue in the treatment of obesity-associated diabetes
- (2016) Christine M. Kusminski et al. NATURE REVIEWS DRUG DISCOVERY
- Persistent metabolic adaptation 6 years after “The Biggest Loser” competition
- (2016) Erin Fothergill et al. Obesity
- How Strongly Does Appetite Counter Weight Loss? Quantification of the Feedback Control of Human Energy Intake
- (2016) David Polidori et al. Obesity
- Energy expenditure and weight control: Is the biggest loser the best loser?
- (2016) Eric Ravussin et al. Obesity
- Pharmacologic Effects of FGF21 Are Independent of the “Browning” of White Adipose Tissue
- (2015) Murielle M. Véniant et al. Cell Metabolism
- Glucagon increases energy expenditure independently of brown adipose tissue activation in humans
- (2015) V. Salem et al. DIABETES OBESITY & METABOLISM
- Physiological adaptations to weight loss and factors favouring weight regain
- (2015) F L Greenway INTERNATIONAL JOURNAL OF OBESITY
- Pharmacological Management of Obesity: An Endocrine Society Clinical Practice Guideline
- (2015) Caroline M. Apovian et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Brown and beige fat in humans: thermogenic adipocytes that control energy and glucose homeostasis
- (2015) Labros Sidossis et al. JOURNAL OF CLINICAL INVESTIGATION
- Liraglutide and obesity: a review of the data so far
- (2015) Ellen Ladenheim Drug Design Development and Therapy
- What We Talk About When We Talk About Fat
- (2014) Evan D. Rosen et al. CELL
- FGF21 Acts Centrally to Induce Sympathetic Nerve Activity, Energy Expenditure, and Weight Loss
- (2014) Bryn M. Owen et al. Cell Metabolism
- Defining the neural basis of appetite and obesity: from genes to behaviour
- (2014) I. S. Farooqi CLINICAL MEDICINE
- Glucagon Is Essential for Adaptive Thermogenesis in Brown Adipose Tissue
- (2014) Keita Kinoshita et al. ENDOCRINOLOGY
- A rationally designed monomeric peptide triagonist corrects obesity and diabetes in rodents
- (2014) Brian Finan et al. NATURE MEDICINE
- The Epidemiology of Obesity: A Big Picture
- (2014) Adela Hruby et al. PHARMACOECONOMICS
- Fibroblast Growth Factor 21 Mediates Specific Glucagon Actions
- (2013) K. M. Habegger et al. DIABETES
- Adaptive thermogenesis in adipocytes: Is beige the new brown?
- (2013) J. Wu et al. GENES & DEVELOPMENT
- Energy balance and its components: implications for body weight regulation
- (2012) Kevin D. Hall et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Mechanism of Fatty-Acid-Dependent UCP1 Uncoupling in Brown Fat Mitochondria
- (2012) Andriy Fedorenko et al. CELL
- Metabolic Disease Drug Discovery— “Hitting the Target” Is Easier Said Than Done
- (2012) David E. Moller Cell Metabolism
- Coadministration of Glucagon-Like Peptide-1 During Glucagon Infusion in Humans Results in Increased Energy Expenditure and Amelioration of Hyperglycemia
- (2012) T. M. Tan et al. DIABETES
- Glucagon increases circulating fibroblast growth factor 21 independently of endogenous insulin levels: a novel mechanism of glucagon-stimulated lipolysis?
- (2012) A. M. Arafat et al. DIABETOLOGIA
- FGF21 regulates PGC-1 and browning of white adipose tissues in adaptive thermogenesis
- (2012) f. M. Fisher et al. GENES & DEVELOPMENT
- Biology's response to dieting: the impetus for weight regain
- (2011) Paul S. MacLean et al. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
- The medical care costs of obesity: An instrumental variables approach
- (2011) John Cawley et al. JOURNAL OF HEALTH ECONOMICS
- Brown adipose tissue activity controls triglyceride clearance
- (2011) Alexander Bartelt et al. NATURE MEDICINE
- The Changed Metabolic World with Human Brown Adipose Tissue: Therapeutic Visions
- (2010) Jan Nedergaard et al. Cell Metabolism
- Targeting energy expenditure via fuel switching and beyond
- (2010) J. G. Geisler DIABETOLOGIA
- The metabolic actions of glucagon revisited
- (2010) Kirk M. Habegger et al. Nature Reviews Endocrinology
- Glucagon-Like Peptide 1/Glucagon Receptor Dual Agonism Reverses Obesity in Mice
- (2009) A. Pocai et al. DIABETES
- A new glucagon and GLP-1 co-agonist eliminates obesity in rodents
- (2009) Jonathan W Day et al. Nature Chemical Biology
- PRDM16 controls a brown fat/skeletal muscle switch
- (2008) Patrick Seale et al. NATURE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now